4,6-diamino-5-n-formamidopyrimidine has been researched along with 2-acetylaminofluorene in 1 studies
Studies (4,6-diamino-5-n-formamidopyrimidine) | Trials (4,6-diamino-5-n-formamidopyrimidine) | Recent Studies (post-2010) (4,6-diamino-5-n-formamidopyrimidine) | Studies (2-acetylaminofluorene) | Trials (2-acetylaminofluorene) | Recent Studies (post-2010) (2-acetylaminofluorene) |
---|---|---|---|---|---|
45 | 0 | 9 | 2,352 | 0 | 97 |
Protein | Taxonomy | 4,6-diamino-5-n-formamidopyrimidine (IC50) | 2-acetylaminofluorene (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.143 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.016 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.595 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.059 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.595 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.143 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 6.053 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ho, YS; Lin, JK; Lo, MJ; Wang, YJ | 1 |
1 other study(ies) available for 4,6-diamino-5-n-formamidopyrimidine and 2-acetylaminofluorene
Article | Year |
---|---|
Oxidative modification of DNA bases in rat liver and lung during chemical carcinogenesis and aging.
Topics: 2-Acetylaminofluorene; Adenine; Aging; Animals; Antineoplastic Agents; Disease Models, Animal; DNA Damage; DNA, Neoplasm; Gas Chromatography-Mass Spectrometry; Guanine; Hydrolysis; Liver; Liver Neoplasms, Experimental; Lung; Lung Neoplasms; Male; Methylamines; Nitrates; Oxidation-Reduction; Pyrimidines; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thymine; Uracil | 1995 |